Matches in Wikidata for { <http://www.wikidata.org/entity/Q82650980> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q82650980 description "article scientifique publié en 2011" @default.
- Q82650980 description "artículu científicu espublizáu en payares de 2011" @default.
- Q82650980 description "bài báo khoa học" @default.
- Q82650980 description "im November 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82650980 description "scientific article published on 01 November 2011" @default.
- Q82650980 description "wetenschappelijk artikel" @default.
- Q82650980 description "наукова стаття, опублікована в листопаді 2011" @default.
- Q82650980 name "[Indication and advantage of combination therapy with angiotensin II receptor blocker (ARB) and calcium channel antagonist]" @default.
- Q82650980 name "[Indication and advantage of combination therapy with angiotensin II receptor blocker (ARB) and calcium channel antagonist]" @default.
- Q82650980 type Item @default.
- Q82650980 label "[Indication and advantage of combination therapy with angiotensin II receptor blocker (ARB) and calcium channel antagonist]" @default.
- Q82650980 label "[Indication and advantage of combination therapy with angiotensin II receptor blocker (ARB) and calcium channel antagonist]" @default.
- Q82650980 prefLabel "[Indication and advantage of combination therapy with angiotensin II receptor blocker (ARB) and calcium channel antagonist]" @default.
- Q82650980 prefLabel "[Indication and advantage of combination therapy with angiotensin II receptor blocker (ARB) and calcium channel antagonist]" @default.
- Q82650980 P1433 Q82650980-B26AE696-9773-417C-A214-64F578818E1F @default.
- Q82650980 P1476 Q82650980-307C418D-0D37-4F41-BF52-A06401128428 @default.
- Q82650980 P2093 Q82650980-1465DF5B-4F3D-45A6-BEB6-37237BDF674B @default.
- Q82650980 P2093 Q82650980-7B1E7540-7153-4D6A-9926-260067A4D269 @default.
- Q82650980 P304 Q82650980-BAF456F3-E447-48DD-A396-89B158B0F944 @default.
- Q82650980 P31 Q82650980-22DA7639-FD91-42E2-B8B1-89F7755635A9 @default.
- Q82650980 P407 Q82650980-35253144-3099-424B-8465-35125D35DD08 @default.
- Q82650980 P433 Q82650980-8EF682CF-F87D-44EF-BA6A-186434EDC4E1 @default.
- Q82650980 P478 Q82650980-2ADAB023-F47B-4901-8F70-2FE1E01519DC @default.
- Q82650980 P50 Q82650980-703A5691-38B7-4CBE-B076-60DEB689E008 @default.
- Q82650980 P577 Q82650980-0E702AAD-583B-4429-B2E6-1F71AD5F4055 @default.
- Q82650980 P698 Q82650980-6D9582A7-BBD2-4BB6-B2FC-A1992DA64E7B @default.
- Q82650980 P698 22111330 @default.
- Q82650980 P1433 Q26841908 @default.
- Q82650980 P1476 "[Indication and advantage of combination therapy with angiotensin II receptor blocker (ARB) and calcium channel antagonist]" @default.
- Q82650980 P2093 "Hiroshi Ogawa" @default.
- Q82650980 P2093 "Junichi Yamaguchi" @default.
- Q82650980 P304 "2059-2063" @default.
- Q82650980 P31 Q13442814 @default.
- Q82650980 P407 Q1860 @default.
- Q82650980 P433 "11" @default.
- Q82650980 P478 "69" @default.
- Q82650980 P50 Q110373760 @default.
- Q82650980 P577 "2011-11-01T00:00:00Z" @default.
- Q82650980 P698 "22111330" @default.